Bannerman Energy seeks shareholder approval for executive remuneration, US$124m placement ratification

**Staff Writer **

Uranium development firm Bannerman Energy Ltd, which is developing the Etango project in the Erongo Region has officially dispatched its notice of meeting and materials to investors ahead of its upcoming Annual General Meeting (AGM), scheduled for Thursday, 5 November 2026.

The meeting will take place physically at the Subiaco Meeting Rooms in Western Australia, alongside a live webcast for digital attendance.

The standard seasonal review of financials for the year ended 30 June 2026 arrives amid a pivotal transitional phase for the company.

Headlining the corporate agenda is a key resolution seeking to formally ratify a massive capital injection.

In mid-September 2026, Bannerman successfully completed an underwritten Australian dollars A$124 million placement to institutional and sophisticated investors at an issue price of A$4 per share.

Led by joint managers Macquarie Capital and Canaccord Genuity, the fresh capital is earmarked to anchor the company’s 55% residual working capital funding requirement for its Etangouranium project, alongside broader growth initiatives.

Approving this item (Resolution 5) will fully restore the company’s 15% discretionary placement capacity under Australian Stock Exchange (ASX) listing rules.

The meeting will also test investor sentiment on updated executive incentive frameworks designed to shepherd the firm from explorer to active producer.

Shareholders are being asked to approve significant Zero Exercise Price Option (ZEPO) equity packages for the company’s top brass.

Managing director and chief executive officer Gavin Chamberlain is up for a proposed 279 958 ZEPOs split across short-term and long-term milestones.

Meanwhile, executive chairman Brandon Munro, who stepped down as managing director in March 2026 to assume the chairmanship, is positioned for an allocation of 173 828 ZEPOs.

Additionally, the board is seeking to increase the maximum aggregate annual fee pool for non-executive directors from A$750 000 to A$1 000 000.

The company noted the cap has remained unchanged since 2008 and requires an upgrade to benchmark against industry medians, ensure robust board succession planning, and accommodate heightened regulatory oversight.

Other voting items include the routine adoption of the company’s remuneration report and the staggered re-elections of directors Danny Goeman, Brandon Munro, and lead independent director/deputy chair Alison Terry.